Hypoxic Preconditioning Increases Survival and Pro-Angiogenic Capacity of Human Cord Blood Mesenchymal Stromal Cells In Vitro
暂无分享,去创建一个
V. Falk | C. Stamm | A. Kurtz | M. Seifert | Yeong-Hoon Choi | K. Bieback | Maria Schneider | K. Klose | D. Korinth | A. Bader | M. Schneider
[1] M. Wood,et al. Therapeutic Potential of Multipotent Mesenchymal Stromal Cells and Their Extracellular Vesicles. , 2015, Human gene therapy.
[2] J. Nolta,et al. Hypoxic Preconditioning of Mesenchymal Stromal Cells Induces Metabolic Changes, Enhances Survival, and Promotes Cell Retention In Vivo , 2015, Stem cells.
[3] K. Hoffmann,et al. Cryopreservation does not alter main characteristics of Good Manufacturing Process-grade human multipotent mesenchymal stromal cells including immunomodulating potential and lack of malignant transformation. , 2015, Cytotherapy.
[4] S. Koh,et al. Hypoxia/Reoxygenation-Preconditioned Human Bone Marrow-Derived Mesenchymal Stromal Cells Rescue Ischemic Rat Cortical Neurons by Enhancing Trophic Factor Release , 2015, Molecular Neurobiology.
[5] K. Webster,et al. Leptin Signaling Is Required for Augmented Therapeutic Properties of Mesenchymal Stem Cells Conferred by Hypoxia Preconditioning , 2014, Stem cells.
[6] Xinyang Hu,et al. Hypoxia Preconditioned Mesenchymal Stem Cells Prevent Cardiac Fibroblast Activation and Collagen Production via Leptin , 2014, PloS one.
[7] C. Stamm,et al. Cord Blood Mesenchymal Stromal Cell-Conditioned Medium Protects Endothelial Cells via STAT3 Signaling , 2014, Cellular Physiology and Biochemistry.
[8] T. Ma,et al. Preconditioning Stem Cells for In Vivo Delivery , 2014, BioResearch open access.
[9] Yonghong Yang,et al. Hypoxia-Pretreated Human MSCs Attenuate Acute Kidney Injury through Enhanced Angiogenic and Antioxidative Capacities , 2014, BioMed research international.
[10] C. Stamm,et al. Mechanisms of paracrine cardioprotection by cord blood mesenchymal stromal cells. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[11] J. Ge,et al. Inducible Metabolic Adaptation Promotes Mesenchymal Stem Cell Therapy for Ischemia: A Hypoxia-Induced and Glycogen-Based Energy Prestorage Strategy , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[12] S. Hung,et al. Hypoxic mesenchymal stem cells engraft and ameliorate limb ischaemia in allogeneic recipients. , 2014, Cardiovascular research.
[13] Xinyang Hu,et al. Increased leptin by hypoxic-preconditioning promotes autophagy of mesenchymal stem cells and protects them from apoptosis , 2014, Science China Life Sciences.
[14] Darcy L. DiFede,et al. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. , 2014, JAMA.
[15] C. Stamm,et al. Impact of heart failure on the behavior of human neonatal stem cells in vitro , 2013, Journal of Translational Medicine.
[16] Mohammad Tariqur Rahman,et al. Hypoxic Culture Conditions as a Solution for Mesenchymal Stem Cell Based Regenerative Therapy , 2013, TheScientificWorldJournal.
[17] A. Das,et al. A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia , 2013, Journal of Translational Medicine.
[18] K. Kang,et al. A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease. , 2013, International journal of stem cells.
[19] T. Couffinhal,et al. Hypoxia-preconditioned mesenchymal stromal cells improve cardiac function in a swine model of chronic myocardial ischaemia. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[20] M. Simionescu,et al. Factors secreted by mesenchymal stem cells and endothelial progenitor cells have complementary effects on angiogenesis in vitro. , 2013, Stem cells and development.
[21] A. Galinier,et al. Aging-related Decrease of Human ASC Angiogenic Potential Is Reversed by Hypoxia Preconditioning Through ROS Production. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[22] Joshua M Hare,et al. Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. , 2012, JAMA.
[23] Ha Won Kim,et al. Concomitant activation of miR-107/PDCD10 and hypoxamir-210/Casp8ap2 and their role in cytoprotection during ischemic preconditioning of stem cells. , 2012, Antioxidants & redox signaling.
[24] Ling Wei,et al. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats , 2012, Neurobiology of Disease.
[25] M. Ashraf,et al. Stem cell-based delivery of Hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of infarcted heart function , 2012, Journal of Molecular Medicine.
[26] W. Xue,et al. The Role of SDF-1-CXCR4/CXCR7 Axis in the Therapeutic Effects of Hypoxia-Preconditioned Mesenchymal Stem Cells for Renal Ischemia/Reperfusion Injury , 2012, PloS one.
[27] Ling Wei,et al. Hypoxic preconditioning enhances bone marrow mesenchymal stem cell migration via Kv2.1 channel and FAK activation. , 2011, American Journal of Physiology - Cell Physiology.
[28] Nan Ma,et al. Cell Origin of Human Mesenchymal Stem Cells Determines a Different Healing Performance in Cardiac Regeneration , 2011, PloS one.
[29] Amir Lerman,et al. Improved survival of mesenchymal stromal cell after hypoxia preconditioning: role of oxidative stress. , 2011, Life sciences.
[30] Periannan Kuppusamy,et al. Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells. , 2010, American journal of physiology. Cell physiology.
[31] Manuel T. Silva. Secondary necrosis: The natural outcome of the complete apoptotic program , 2010, FEBS letters.
[32] W. Xue,et al. Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1α in MSCs. , 2010, Biochemical and biophysical research communications.
[33] T. Couffinhal,et al. Hypoxia Preconditioned Mesenchymal Stem Cells Improve Vascular and Skeletal Muscle Fiber Regeneration After Ischemia Through a Wnt4-dependent Pathway. , 2010, Molecular Therapy.
[34] Shujia Jiang,et al. Ischemic Preconditioning Augments Survival of Stem Cells via miR-210 Expression by Targeting Caspase-8-associated Protein 2* , 2009, The Journal of Biological Chemistry.
[35] B. Trimarco,et al. Cross-Talk Between PKA and Akt Protects Endothelial Cells From Apoptosis in the Late Ischemic Preconditioning , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[36] Yong Sun,et al. The antiapoptotic effect of mesenchymal stem cell transplantation on ischemic myocardium is enhanced by anoxic preconditioning. , 2009, The Canadian journal of cardiology.
[37] Jun Jiang,et al. Anoxic preconditioning: a way to enhance the cardioprotection of mesenchymal stem cells. , 2009, International journal of cardiology.
[38] D. Link,et al. Hypoxic Preconditioning Results in Increased Motility and Improved Therapeutic Potential of Human Mesenchymal Stem Cells , 2008, Stem cells.
[39] Ling Wei,et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. , 2008, The Journal of thoracic and cardiovascular surgery.
[40] Jun Jiang,et al. Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells , 2008, Acta Pharmacologica Sinica.
[41] Hong Chen,et al. Delayed cytoprotection induced by hypoxic preconditioning in cultured neonatal rat cardiomyocytes: role of GRP78. , 2007, Life sciences.
[42] Nan Ma,et al. Bcl‐2 Engineered MSCs Inhibited Apoptosis and Improved Heart Function , 2007, Stem cells.
[43] M. Ashraf,et al. Bone Marrow Stem Cells Prevent Left Ventricular Remodeling of Ischemic Heart Through Paracrine Signaling , 2006, Circulation research.
[44] Hoon Han,et al. Successful Stem Cell Therapy Using Umbilical Cord Blood‐Derived Multipotent Stem Cells for Buerger's Disease and Ischemic Limb Disease Animal Model , 2006, Stem cells.
[45] Hermann Eichler,et al. Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue , 2006, Stem cells.
[46] Young Jin Kim,et al. Isolation of Mesenchymal Stem Cells from Cryopreserved Human Umbilical Cord Blood , 2005, International journal of hematology.
[47] Myoung-Woo Lee,et al. Mesenchymal stem cells from cryopreserved human umbilical cord blood. , 2004, Biochemical and biophysical research communications.
[48] N. Maulik,et al. Role of Akt Signaling in Mitochondrial Survival Pathway Triggered by Hypoxic Preconditioning , 2004, Circulation.